Form 4: C4 Therapeutics Chief Medical Officer Leonard Reyno Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Chief Medical Officer of C4 Therapeutics, Leonard Reyno, reports a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.
Summary
- On July 10, 2024, Leonard Reyno, the Chief Medical Officer of C4 Therapeutics, Inc. (CCCC), had shares withheld by the issuer to satisfy tax withholding obligations.
- This transaction involved 6,191 shares of common stock.
- Following the transaction, Reyno beneficially owns 91,809 shares of C4 Therapeutics stock directly.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to tax obligations, and it doesn't inherently convey positive or negative sentiment. It's a neutral reporting of a routine transaction.
Industry Context
Form 4 filings are routine and provide transparency into insider transactions, allowing investors to track management's holdings and potential alignment with shareholder interests. This specific transaction relates to tax obligations, which is a common occurrence.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax-related event.
Key Dates
| Date | Description |
|---|---|
| 07/10/2024 | Date of the stock transaction (tax withholding). |
| 07/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.